CryoLife Company Profile (NYSE:CRY)

About CryoLife

CryoLife logoCryoLife, Inc. (CryoLife) is engaged in medical device manufacturing and distribution, and in the processing and distribution of implantable human tissues for cardiac and vascular surgeries. The Company operates in two segments: Medical Devices and Preservation Services. The Medical Devices segment sells BioGlue, BioFoam, PerClot, CardioGenesis cardiac laser therapy, Hemodialysis Reliable Outflow (HeRO) Graft, and ProCol Vascular Bioprosthesis (ProCol). The Preservation Services segment preserves cardiac and vascular tissues. The Company's surgical sealants and hemostats include BioGlue Surgical Adhesive (BioGlue), BioFoam Surgical Matrix (BioFoam), and PerClot, an absorbable powdered hemostat, which the Company distributes internationally for Starch Medical, Inc. (SMI). Its CardioGenesis cardiac laser therapy product line includes a laser console system and single-use, fiber-optic handpieces.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: CRY
  • CUSIP: 22890310
Key Metrics:
  • Previous Close: $17.82
  • 50 Day Moving Average: $16.36
  • 200 Day Moving Average: $12.98
  • 52-Week Range: $8.94 - $18.64
  • Trailing P/E Ratio: 57.12
  • Foreward P/E Ratio: 45.69
  • P/E Growth: 1.82
  • Market Cap: $607.84M
  • Outstanding Shares: 34,110,000
  • Beta: 1.14
  • Net Margins: 5.80%
  • Return on Equity: 8.15%
  • Return on Assets: 5.93%
  • Debt-to-Equity Ratio: 0.36%
  • Current Ratio: 5.49%
  • Quick Ratio: 4.46%
Additional Links:
Companies Related to CryoLife:

Analyst Ratings

Consensus Ratings for CryoLife (NYSE:CRY) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $14.25 (20.03% downside)

Analysts' Ratings History for CryoLife (NYSE:CRY)
DateFirmActionRatingPrice TargetDetails
7/27/2016Piper Jaffray Cos.Reiterated RatingOverweight$16.00View Rating Details
7/26/2016Canaccord GenuityReiterated RatingBuyView Rating Details
6/15/2016Lake Street CapitalInitiated CoverageBuy$15.00View Rating Details
4/28/2016Ladenburg ThalmannDowngradeBuy -> Neutral$12.00View Rating Details
5/18/2015First AnalysisInitiated CoverageOverweight$14.00View Rating Details
(Data available from 9/27/2014 forward)


Earnings History for CryoLife (NYSE:CRY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/25/2016Q216$0.02$0.13$35.50 million$47.10 millionViewListenView Earnings Details
4/27/2016Q116$0.02$0.10$40.50 million$43.00 millionViewListenView Earnings Details
2/16/2016Q415$0.05$0.13$40.04 million$39.80 millionViewListenView Earnings Details
10/27/2015Q315$0.01$0.10$38.17 million$36.70 millionViewListenView Earnings Details
7/28/2015Q215$0.03$35.57 million$35.50 millionViewListenView Earnings Details
4/28/2015Q115$0.01($0.01)$36.55 million$33.80 millionViewListenView Earnings Details
2/17/2015Q414$0.05$0.04$37.42 million$37.20 millionViewListenView Earnings Details
10/28/2014Q314$0.05$0.08$37.70 million$37.10 millionViewListenView Earnings Details
7/24/2014Q214$0.05$0.08$35.72 million$34.69 millionViewListenView Earnings Details
4/29/2014Q114$0.07$0.04$37.30 million$35.73 millionViewListenView Earnings Details
2/20/2014Q413$0.35$0.31$34.90 million$35.50 millionViewListenView Earnings Details
10/29/2013Q313$0.05$0.12$35.51 million$36.30 millionViewListenView Earnings Details
7/25/2013Q2 2013$0.07$0.08$35.63 million$33.50 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.07$0.08$35.04 million$35.50 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.05$0.08$33.58 million$32.80 millionViewListenView Earnings Details
10/30/2012Q312$0.04$0.08$32.45 million$33.40 millionViewN/AView Earnings Details
7/31/2012$0.05$0.10ViewN/AView Earnings Details
4/26/2012$0.05$0.04ViewN/AView Earnings Details
2/16/2012$0.06$0.07ViewN/AView Earnings Details
10/27/2011$0.08$0.07ViewN/AView Earnings Details
7/28/2011$0.06$0.12ViewN/AView Earnings Details
4/28/2011$0.08$0.09ViewN/AView Earnings Details
2/17/2011$0.07$0.08ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CryoLife (NYSE:CRY)
Current Year EPS Consensus Estimate: $0.34 EPS
Next Year EPS Consensus Estimate: $0.39 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.01$0.01$0.01
Q2 20162$0.01$0.02$0.02
Q3 20162$0.01$0.04$0.03
Q4 20162$0.02$0.07$0.05
Q1 20172$0.04$0.06$0.05
Q2 20172$0.07$0.07$0.07
Q3 20171$0.07$0.07$0.07
Q4 20171$0.09$0.09$0.09
(Data provided by Zacks Investment Research)


Current Dividend Information for CryoLife (NYSE:CRY)
Annual Dividend:$0.03
Dividend Yield:0.17%
Dividend Growth:33.90% (3 Year Average)
Payout Ratio:9.68% (Based on Trailing 12 Months of Earnings)
8.82% (Based on Current Year Consensus EPS Estimate)
7.69% (Based on Next Year Consensus EPS Estimate)
Track Record:3 Years of Consecutive Dividend Growth

Dividend History for CryoLife (NYSE:CRY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for CryoLife (NYSE:CRY)
Insider Ownership Percentage: 6.08%
Institutional Ownership Percentage: 58.13%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/26/2016C Elkins RonaldDirectorSell2,000$14.00$28,000.00View SEC Filing  
6/1/2016Ronald D MccallDirectorSell10,000$11.56$115,600.00View SEC Filing  
5/10/2016James BensonDirectorSell5,000$12.22$61,100.00View SEC Filing  
4/15/2016C Elkins RonaldDirectorSell1,000$12.00$12,000.00View SEC Filing  
3/7/2016C Elkins RonaldDirectorSell2,000$11.18$22,360.00View SEC Filing  
3/4/2016James P MackinCEOBuy10,000$10.91$109,100.00View SEC Filing  
2/19/2016Scott B CappsVPSell15,000$10.30$154,500.00View SEC Filing  
2/18/2016David Ashley LeeCFOSell8,000$10.13$81,040.00View SEC Filing  
12/28/2015David Ashley LeeCFOSell700$11.00$7,700.00View SEC Filing  
11/30/2015David Ashley LeeCFOSell11,800$11.03$130,154.00View SEC Filing  
9/15/2015James BensonDirectorSell5,839$9.65$56,346.35View SEC Filing  
9/11/2015James BensonDirectorSell3,359$9.65$32,414.35View SEC Filing  
2/19/2015Steven G AndersonChairmanSell30,000$10.93$327,900.00View SEC Filing  
12/9/2014Bruce G AndersonVPSell3,900$10.29$40,131.00View SEC Filing  
11/25/2014Bruce G AndersonVPSell20,211$10.11$204,333.21View SEC Filing  
11/5/2014C Elkins RonaldDirectorSell4,000$10.08$40,320.00View SEC Filing  
11/3/2014James BensonDirectorSell10,000$10.22$102,200.00View SEC Filing  
9/8/2014Bruce G AndersonVPSell10,000$10.05$100,500.00View SEC Filing  
9/2/2014Steven G AndersonChairmanSell20,000$10.08$201,600.00View SEC Filing  
8/25/2014Bruce G AndersonVPSell5,000$10.05$50,250.00View SEC Filing  
8/18/2014Bruce G AndersonVPSell10,000$10.52$105,200.00View SEC Filing  
8/14/2014David Ashley LeeCFOSell10,000$10.51$105,100.00View SEC Filing  
8/13/2014David Ashley LeeCFOSell9,881$10.51$103,849.31View SEC Filing  
8/13/2014Jeffrey W BurrisVPSell11,000$10.50$115,500.00View SEC Filing  
7/29/2014C Elkins RonaldDirectorSell2,500$9.67$24,175.00View SEC Filing  
7/28/2014Bruce G AndersonVPSell5,000$9.48$47,400.00View SEC Filing  
7/28/2014Steven G AndersonCEOSell19,477$9.52$185,421.04View SEC Filing  
6/9/2014Amy HortonCAOSell2,500$9.26$23,150.00View SEC Filing  
5/16/2014David FronkVPSell8,952$8.61$77,076.72View SEC Filing  
5/13/2014Steven AndersonCEOSell30,523$9.00$274,707.00View SEC Filing  
5/6/2014Bruce AndersonVPSell16,870$8.83$148,962.10View SEC Filing  
11/26/2013Jeffrey BurrisVPSell5,000$10.50$52,500.00View SEC Filing  
11/11/2013Jeffrey BurrisVPSell5,000$10.00$50,000.00View SEC Filing  
11/7/2013Steven AndersonCEOSell100,000$9.38$938,000.00View SEC Filing  
10/29/2013C Elkins RonaldDirectorSell2,000$9.00$18,000.00View SEC Filing  
10/29/2013Jeffrey W BurrisVPSell5,000$9.00$45,000.00View SEC Filing  
8/27/2013Bruce AndersonVPSell4,500$6.33$28,485.00View SEC Filing  
8/8/2013Amy HortonCAOSell2,500$7.07$17,675.00View SEC Filing  
8/1/2013Ronald D MccallDirectorSell6,000$7.10$42,600.00View SEC Filing  
6/6/2013Ronald D MccallDirectorSell4,000$6.15$24,600.00View SEC Filing  
5/31/2013C Elkins RonaldDirectorSell2,250$6.15$13,837.50View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for CryoLife (NYSE:CRY)
DateHeadline logoCryoLife, Inc. (NYSE:CRY)'s Accounts Payable Is $5.204 - (NYSE:CRY) - September 23 at 4:15 PM logoGlobal Regenerative Medicine Market Is Expected to Reach $30,237 Million by 2022; Finds New Report (NYSE:CRY) - September 23 at 9:33 AM logoCryoLife Hits a 52-Week High on Strong Growth Prospects (NYSE:CRY) - September 23 at 9:33 AM
News IconWhat is the Sell-side Saying About CryoLife, Inc. (NYSE:CRY)? - Frisco Fastball (NYSE:CRY) - September 22 at 10:01 AM logoSyneron Medical (ELOS) in Focus: Stock Moves 5.9% Higher (NYSE:CRY) - September 22 at 10:01 AM
News IconWere Analysts Bullish Cryolife Inc (NYSE:CRY) This Week? - Post News (NYSE:CRY) - September 21 at 8:40 AM logoBaxter (BAX) Now a Strong Buy on Solid Strategic Initiatives (NYSE:CRY) - September 19 at 3:17 PM logoCryoLife to Present at Ladenburg Thalmann 2016 Healthcare Conference (NYSE:CRY) - September 19 at 9:05 AM
News IconWhat Will Happen to Cryolife Inc Next? The Stock Just Reaches 52 ... - Post News (NYSE:CRY) - September 18 at 4:19 PM logoCryoLife, Inc. (NYSE:CRY) Accounts Payable Is $5.204 - (NYSE:CRY) - September 17 at 4:19 PM logoCryoLife : Appoints James McDermid as Chief Human Resources Officer (NYSE:CRY) - September 17 at 9:07 AM
News IconMedical Adhesives Market 2016 Global Trends, Market Share, Industry Size, Growth, Opportunities, and Forecast to 2022 (NYSE:CRY) - September 16 at 4:16 PM
News IconSell-side Consensus Sees CryoLife, Inc. (NYSE:CRY) Going Where Near-Term? - Frisco Fastball (NYSE:CRY) - September 15 at 9:26 AM logoCryoLife Has Returned 64.7% Since SmarTrend Recommendation (CRY) (NYSE:CRY) - September 14 at 4:31 PM
News IconAnalyst Expectations and Growth Review for CryoLife Inc. (NYSE:CRY) - Post News (NYSE:CRY) - September 14 at 8:02 AM logoIs CryoLife an Incredible Momentum Stock? 3 Reasons Why CRY Will Be Tough to Beat (NYSE:CRY) - September 12 at 9:17 AM logo2016 Tissue Heart Valves Medical Devices Pipeline Market Products by Segment Assessment (NYSE:CRY) - September 10 at 9:03 AM logoCryoLife to Present at Morgan Stanley Global Healthcare Conference (NYSE:CRY) - September 9 at 4:20 PM logoVarian (VAR) Acquires Radiotherapy Business of Candela (NYSE:CRY) - September 9 at 4:20 PM
News IconShares Seen Moving Up to a Recent High: CryoLife Inc. (NYSE:CRY ... - Post News (NYSE:CRY) - September 9 at 9:17 AM logoShares Trading unchanged at $16.43 CryoLife to Present at Morgan Stanley… (NYSE:CRY) - September 8 at 4:19 PM logoShares Trading unchanged at $16.43 CryoLife to Present at Morgan Stanley… (NYSE:CRY) - September 8 at 4:19 PM logoCryoLife to Present at Morgan Stanley Global Healthcare Conference - PR Newswire (press release) (NYSE:CRY) - September 7 at 4:32 PM
News IconStock Showing Gains in Today's Session: CryoLife Inc. (NYSE:CRY ... - Post News (NYSE:CRY) - September 7 at 4:32 PM
News IconStock Noted Climbing Up to a Recent High: CryoLife Inc. (NYSE ... - Post News (NYSE:CRY) - September 7 at 4:32 PM logoCryoLife Appoints James McDermid as Chief Human Resources ... - PR Newswire (press release) (NYSE:CRY) - September 6 at 9:24 PM logoETF’s with exposure to CryoLife, Inc. : September 6, 2016 (NYSE:CRY) - September 6 at 4:19 PM logoNuVasive Hits 52-Week High on Solid Q2 & Strategic Tie-Ups (NYSE:CRY) - September 6 at 4:19 PM logoCryoLife Appoints James McDermid as Chief Human Resources Officer (NYSE:CRY) - September 6 at 9:17 AM logoCryoLife, Inc. (NYSE:CRY) Is Expected To Post EPS Of $0.06 - (NYSE:CRY) - September 3 at 9:02 AM logoRegenerative Medicine World Market Segmentation and Major Players Analysis 2022 (NYSE:CRY) - September 2 at 4:12 PM
News IconRegenerative Medicine Market to Reach $30,237 Million, Globally, by 2022 (NYSE:CRY) - September 1 at 10:42 AM
News IconShares Marching Up to a Recent High: CryoLife Inc. (NYSE:CRY) - Post News (NYSE:CRY) - August 31 at 9:14 AM logoShares of CRY Up 48.1% Since Uptrend Call on Shares (NYSE:CRY) - August 26 at 4:35 PM
News IconSurgical Sealants and Adhesives Market 2016: Industry Review and Growth to 2022 (NYSE:CRY) - August 19 at 10:32 AM logoBioTelemetry (BEAT) Scales New 52-Week High on Solid Q2 (NYSE:CRY) - August 19 at 10:32 AM logo49.9% Return Seen to Date on SmarTrend CryoLife Call (CRY) (NYSE:CRY) - August 19 at 10:32 AM logoCryoLife (CRY) Raised to Strong Buy on Solid Q2 Results (NYSE:CRY) - August 12 at 4:28 PM logoNew Strong Buy Stocks for August 12th (NYSE:CRY) - August 12 at 10:00 AM
News IconReport Published: "Tissue Heart Valves - Medical Devices Pipeline Assessment, 2016" (NYSE:CRY) - August 11 at 4:34 PM logo45.3% Return Seen to Date on SmarTrend CryoLife Call (CRY) (NYSE:CRY) - August 11 at 4:34 PM logoCryoLife to Present at 2016 Wedbush PacGrow Healthcare Conference (NYSE:CRY) - August 11 at 10:19 AM logoBioadhesives Market: Opportunities and Forecasts 2015 to 2021 (NYSE:CRY) - August 5 at 9:44 PM logoCryoLife to Present at 36th Annual Canaccord Genuity Growth Conference (NYSE:CRY) - August 4 at 10:07 PM logoETF’s with exposure to CryoLife, Inc. : August 2, 2016 (NYSE:CRY) - August 2 at 4:32 PM logoCryoLife, Inc. :CRY-US: Earnings Analysis: Q2, 2016 By the Numbers : August 1, 2016 (NYSE:CRY) - August 1 at 4:24 PM logoCRYOLIFE INC Financials (NYSE:CRY) - July 30 at 1:04 PM logoCryolife : Susan Gunderson of St. Paul, Minnesota Receives Achievement Award from Association of Organ Procurement Organizations (NYSE:CRY) - July 30 at 10:38 AM
News IconCryoLife Inc. (CRY) Releases FY16 Earnings Guidance (NYSE:CRY) - July 28 at 11:26 AM logoCryoLife, Inc.: Strong price momentum but will it sustain? (NYSE:CRY) - July 27 at 4:23 PM


CryoLife (NYSE:CRY) Chart for Tuesday, September, 27, 2016

Last Updated on 9/27/2016 by Staff